Rumbaoa, Reynie P.
HRN: 22-28-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2022
CEFTRIAXONE 1G (VIAL)
12/01/2022
12/07/2022
IVT
2g
OD
Covid 19 Infection Mild; Severe Anemia Sec To UGIB Sec To Chronic NSAID Use,
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes